Download PDF (external access)

Acta Cardiologica

Publication date: 2013-02-01
Volume: 68
Publisher: Taylor & Francis

Author:

Bennett, Johan
Dens, Joseph ; Stammen, Francis ; Coussement, Patrick ; Janssens, Luc ; Claeys, Marc ; Vrolix, Mathias ; Sinnaeve, Peter ; Dubois, Christophe ; Desmet, Walter

Keywords:

Female, Follow-Up Studies, Humans, Male, Percutaneous Coronary Intervention, Polytetrafluoroethylene, Prospective Studies, Prosthesis Design, Saphenous Vein, Stents, Time Factors, Covered stent, saphenous vein graft intervention, embolic protection device, percutaneous coronary intervention, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, IMPLANTATION, OUTCOMES, LESIONS, EVENTS, 1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, 3201 Cardiovascular medicine and haematology

Abstract:

The long-term clinical outcome of covered stents in the percutaneous treatment of diseased saphenous vein graft (SVG) has been disappointing. The single self-expanding polytetrafluoroethylene (PTFE)-covered Symbiot stent with a unique profile may present advantages that translate into superior long-term clinical outcomes. This study evaluated the safety, effectiveness and clinical outcome of the Symbiot covered stent system (Boston Scientific, Natick, Mass.) and FilterWire EX (Boston Scientific, Natick, Mass.) versus bare metal stents (BMS) in SVG intervention.